Skip to Content

Fluxid Approval History

FDA Approved: Yes (Discontinued) (First approved September 24, 2004)
Brand name: Fluxid
Generic name: famotidine
Dosage form: Orally Disintegrating Tablets
Company: Schwarz Pharma, Inc.
Treatment for: Duodenal Ulcer, Stomach Ulcer, GERD, Zollinger-Ellison Syndrome

Marketing Status: Discontinued

Fluxid (famotidine orally disintegrating tablets) is a histamine H2-receptor antagonist indicated for the treatment of ulcers, gastroesophageal reflux disease and pathological hypersecretory conditions.

Development History and FDA Approval Process for Fluxid

DateArticle
Sep 24, 2004Approval Fluxid Schwarz Pharma, Inc. - Treatment for Ulcers and other Gastrointestinal Conditions

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide